“Unparalleled expertise and strong Track record since 30 years”
Since 30 years FERBER & CO. is acting as a leading M&A and corporate finance advisor in the German Healthcare sector which is highly attractive due to its low cyclicality, high barriers to entry and strong financial position of its market participants. As the population is aging spendings are increasing with new technologies constantly advancing. Our expertise encompasses an unrivalled range of subsectors from pharma/OTC to ambulant and stationary care, pharma distribution and wholesale to medical devices and digitalization/AI.
Our clients include entrepreneurs, healthcare practitioners and doctors, pharmacists, large pharma, care or clinic corporates as well as globally active healthcare investors who benefit from our unprecedented sector approach and our strong network in the sector.
Pharma
Pharmacies & Wholesale
Acute & Non-Acute
Care
Healthcare Tech
Recent Transactions
in the Healthcare sector
Dermapharm has acquired Arkopharma SE from Montagu Private Equity LLP.
We acted as advisor to the buyer.
Apurano Pharmaceuticals successfully completed the realignment of its shareholder base including a private placement to secure its further expansion.
We initiated the transaction and advised Apurano Pharmaceuticals in its funding round.
Vitafy Brands and EVP Group have merged.
We acted as advisor to Vitafy Brands and its shareholders.
Dermapharm has acquired C3 – Cannabinoid Compound Company GmbH from Canopy Growth Corporation.
We acted as advisor to the buyer.
Dermazentrum sold a majority ownership stake in an Owners Buy-out to Halder.
We advised Dermazentrum and its founder.
Wellster Healthtech successfully completed a USD 40m private placement led by a group of investors.
We advised and supported Wellster Healthtech in its funding round.
Permira Beteiligungsberatung has acquired Neuraxpharm from Apax Partners.
We acted as advisor to the buyer.
Oakley Capital has acquired WindStar Medical GmbH from ProSiebenSat.1 majority-owned NuCom Group.
We acted as advisor to the buyer.
We initiated the transaction and acted as advisor to Heinz-Peter Fichter and Apotal group.
Dermapharm has acquired Allergopharma GmbH & Co. KG, a subsidiary of Merck KGaA.
We acted as advisor to the buyer.
Dermapharm AG has acquired 70% of the shares in Fitvia GmbH.
We acted as advisor to the buyer.
Advent International has acquried Lavorel Medicare and Bonitas.
We acted as advisor to the buyer.
Zur Rose Group and DocMorris have acquired medpex.
We acted as advisor to the buyer.
Dermapharm AG has acquired Euromed from Riverside.
We acted as advisor to the buyer.
Point Rouge has acquired ascopharm from Pagoda and Adiuva Capital.
We acted as advisor to the buyer.
Aenova, a portfolio company of BC Partners, has sold 100% of the shares in Euro Vital Pharma to Capiton and the management.
We initiated the transaction and acted as advisor to the sellers.
Zur Rose Group and DocMorris have acquired Apotheke am Rothenbaum (apo-rot).
We initiated the transaction and acted as advisor to the buyer.
Advent International has acquired Deutsche Fachpflege Gruppe from Chequers Capital.
We initiated the transaction and acted as advisor to the buyer.
Dermapharm AG has acquired 100% of the shares in Trommsdorff from Grupo Ferrer.
We initiated the transaction and acted as advisor to the buyer.
Dermapharm AG has acquired 100% of the shares in Strathmann.
We acted as advisor to the buyer.
Trilantic Capital Partners has acquired 100% of the shares in Oberberg Klinik group from Odewald & Compagnie.
We acted as advisor to the buyer.